Stay updated on Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T15:45:44.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 with no changes to study details or locations.
    Difference
    0.0%
    Check dated 2026-03-11T17:20:50.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    A new site revision marker 'Revision: v3.4.2' was added and the previous 'Revision: v3.4.1' marker was removed. These are routine site maintenance/versioning updates and do not affect study content or availability; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:34:38.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Administrative notices were added: a government funding lapse notice with status guidance, and a software revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:23:25.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Glossary display is now shown, and new metadata labels include Last Update Submitted that Met QC Criteria and Last Update Posted. The revision label has been updated to v3.4.0, and older labels such as Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), and No FEAR Act data have been removed or renamed.
    Difference
    0.2%
    Check dated 2026-01-28T03:53:56.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces the previous v3.3.3 on the page. This is a minor update that does not affect study content or user-facing information; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:03:56.000Z thumbnail image

Stay in the know with updates to Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial page.